Release of Institut Mérieux’s Newsletter #9
The latest issue of Institut Mérieux’s Newsletter is now available on our website. Please click here Institut Mérieux’s Newsletter provides all the latest news about the Institute and its companies. This issue presents some of the major projects of the Institute's companies plus a special feature on the Foundation's actions in the Middle East.
MARC BONNEVILLE: NEW CHAIRMAN OF THE ARIIS
Marc Bonneville, Vice President of Medical and Scientific Affairs at Institut Mérieux will be taking over as Chairman of the Alliance for Research and Innovation in the Healthcare Industries (ARIIS). The purpose of this professional organisation affiliated to the French … Read more
3 NEW YOUNG INVESTIGATORS AWARDS
A keen advocate of biology without borders, Institut Mérieux is committed to supporting research in emerging countries. Every year, the Young Investigators Awards reward young and promising researchers and investigators in emerging and developing countries. Last summer, three prices have been awarded. … Read more
Franco-Chinese collaboration on tuberculosis diagnosis
The Chinese Academy of Medical Sciences, the Chinese Center for Disease Control and the Institut Mérieux held a symposium on tuberculosis diagnosis in Beijing on September 13-14. About 30 international scientific experts shared information on multidrug-resistant tuberculosis, a major public … Read more
The 2016 Christophe Mérieux Prize
Professor Francine Ntoumi, from the Faculty of Science and Technology in Brazzaville (Congo), has been awarded the 2016 Christophe Mérieux Prize. She was awarded the €500,000 prize on June 8, 2016 in Paris by the Institut de France, on … Read more
MESSAGE FROM THE CHAIRMAN
“ The threat of infectious disease is always present,
as the emergence of new epidemics reminds us.
However, we are fortunate that unprecedented scientific and technological
breakthroughs are making it possible to provide new medical solutions.
The science and the public health challenges are both extremely complex, requiring a global approach to health care: an interdisciplinary, network-based approach, without borders of any kind, that is patient-centered and guarantees the same level of care to all patients regardless of their country of origin.
This is Institut Mérieux’s vision of health care, which inspires all of our activities
and our commitment to pushing the boundaries of biology. ”
Alain Mérieux, Chairman
Institut Mérieux is contributing its experience in industrial biology to improve medicine and public health across the globe.
VISION AND COMMITMENTS
As a perfect blend of tradition and innovation, Institut Mérieux works ceaselessly to push the boundaries of biology to improve the quality of patient care and consumer health…
A REFERENCE SHAREHOLDER
FONDATION CHRISTOPHE ET RODOLPHE MÉRIEUX
Since 2005, Fondation Christophe et Rodolphe Mérieux, under the aegis of Institut de France, has been a one-third shareholder in Institut Mérieux. The Foundation indirectly collects the only dividends that Institut Mérieux distributes in order to finance its activities in the field.
Its core activities include promoting local research, providing treatment and rehabilitation, and supporting mothers and children.
This independent family foundation was created by Chantal and Alain Mérieux in 2001. Fondation Christophe et Rodolphe Mérieux works in the field to fight against infectious diseases in disadvantaged countries.
Institut Mérieux’s governance is founded on experienced leadership teams that have a shared vision of public health. The role of Institut Mérieux is to provide strategic guidance for its different companies and promote exchanges and synergies between all areas.